The global Lentivirus Particle market was valued at US$ 287.1 million in 2022 and is projected to reach US$ 380.7 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Lentivirus particles have been widely used in biomedical research, particularly in the field of gene therapy and gene delivery. Lentiviruses, such as the human immunodeficiency virus (HIV), have been modified to be non-replicative and used as vectors to deliver genetic material into target cells. This delivery system enables the introduction of specific genes or genetic modifications into cells for various applications, including research, drug development, and potential therapeutic interventions.
The lentivirus particle market has seen significant growth due to the expanding interest in gene therapy, gene editing, and other genetic research applications. Lentiviral vectors offer several advantages, including their ability to infect both dividing and non-dividing cells, stable gene expression over extended periods, and a broad range of target cell compatibility.
Future development trends in the lentivirus particle market include:
Enhanced Safety and Efficiency: Ongoing research aims to improve the safety and efficiency of lentivirus-based gene delivery systems. This includes developing new vector designs, modifying viral components, and optimizing transduction protocols.
Targeted Delivery: Efforts are being made to enhance the specificity of lentiviral vectors by incorporating targeting ligands or using tissue-specific promoters. This enables more precise delivery of therapeutic genes to specific cell types or tissues.
Large-Scale Production: As demand for lentivirus particles increases, there is a need for scalable and cost-effective production methods. Advances in large-scale manufacturing techniques and purification processes are anticipated to support the growth of the market.
Regulatory Considerations: The lentivirus particle market is subject to regulatory oversight due to safety concerns associated with the use of viral vectors. Future developments may involve addressing regulatory requirements and guidelines to ensure safe and effective use of lentiviral-based therapies.
This report aims to provide a comprehensive presentation of the global market for Lentivirus Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lentivirus Particle. This report contains market size and forecasts of Lentivirus Particle in global, including the following market information:
Global Lentivirus Particle Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lentivirus Particle companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lentivirus Particle Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Lentivirus Particle Market Segment Percentages, by Type, 2022 (%)
Custom-made
Pre-made
Global Lentivirus Particle Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Lentivirus Particle Market Segment Percentages, by Application, 2022 (%)
Gene Expression
Gene Editing
Cell Line Development
Gene Therapy
Others
Global Lentivirus Particle Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Lentivirus Particle Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lentivirus Particle revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Lentivirus Particle revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AMSBIO
Creative Biogene
Cellomics Technology
GenTarget
Takara Bio
GeneCopoeia
OriGene
GenScript
Addgene
System Biosciences
BPS Bioscience
Charles River
Santa Cruz Biotechnology
Sigma-Aldrich
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lentivirus Particle, market overview.
Chapter 2: Global Lentivirus Particle market size in revenue.
Chapter 3: Detailed analysis of Lentivirus Particle company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lentivirus Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Lentivirus Particle Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lentivirus Particle Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lentivirus Particle Overall Market Size
2.1 Global Lentivirus Particle Market Size: 2022 VS 2029
2.2 Global Lentivirus Particle Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lentivirus Particle Players in Global Market
3.2 Top Global Lentivirus Particle Companies Ranked by Revenue
3.3 Global Lentivirus Particle Revenue by Companies
3.4 Top 3 and Top 5 Lentivirus Particle Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lentivirus Particle Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lentivirus Particle Players in Global Market
3.6.1 List of Global Tier 1 Lentivirus Particle Companies
3.6.2 List of Global Tier 2 and Tier 3 Lentivirus Particle Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lentivirus Particle Market Size Markets, 2022 & 2029
4.1.2 Custom-made
4.1.3 Pre-made
4.2 By Type - Global Lentivirus Particle Revenue & Forecasts
4.2.1 By Type - Global Lentivirus Particle Revenue, 2018-2023
4.2.2 By Type - Global Lentivirus Particle Revenue, 2024-2029
4.2.3 By Type - Global Lentivirus Particle Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lentivirus Particle Market Size, 2022 & 2029
5.1.2 Gene Expression
5.1.3 Gene Editing
5.1.4 Cell Line Development
5.1.5 Gene Therapy
5.1.6 Others
5.2 By Application - Global Lentivirus Particle Revenue & Forecasts
5.2.1 By Application - Global Lentivirus Particle Revenue, 2018-2023
5.2.2 By Application - Global Lentivirus Particle Revenue, 2024-2029
5.2.3 By Application - Global Lentivirus Particle Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Lentivirus Particle Market Size, 2022 & 2029
6.2 By Region - Global Lentivirus Particle Revenue & Forecasts
6.2.1 By Region - Global Lentivirus Particle Revenue, 2018-2023
6.2.2 By Region - Global Lentivirus Particle Revenue, 2024-2029
6.2.3 By Region - Global Lentivirus Particle Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Lentivirus Particle Revenue, 2018-2029
6.3.2 US Lentivirus Particle Market Size, 2018-2029
6.3.3 Canada Lentivirus Particle Market Size, 2018-2029
6.3.4 Mexico Lentivirus Particle Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Lentivirus Particle Revenue, 2018-2029
6.4.2 Germany Lentivirus Particle Market Size, 2018-2029
6.4.3 France Lentivirus Particle Market Size, 2018-2029
6.4.4 U.K. Lentivirus Particle Market Size, 2018-2029
6.4.5 Italy Lentivirus Particle Market Size, 2018-2029
6.4.6 Russia Lentivirus Particle Market Size, 2018-2029
6.4.7 Nordic Countries Lentivirus Particle Market Size, 2018-2029
6.4.8 Benelux Lentivirus Particle Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Lentivirus Particle Revenue, 2018-2029
6.5.2 China Lentivirus Particle Market Size, 2018-2029
6.5.3 Japan Lentivirus Particle Market Size, 2018-2029
6.5.4 South Korea Lentivirus Particle Market Size, 2018-2029
6.5.5 Southeast Asia Lentivirus Particle Market Size, 2018-2029
6.5.6 India Lentivirus Particle Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Lentivirus Particle Revenue, 2018-2029
6.6.2 Brazil Lentivirus Particle Market Size, 2018-2029
6.6.3 Argentina Lentivirus Particle Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lentivirus Particle Revenue, 2018-2029
6.7.2 Turkey Lentivirus Particle Market Size, 2018-2029
6.7.3 Israel Lentivirus Particle Market Size, 2018-2029
6.7.4 Saudi Arabia Lentivirus Particle Market Size, 2018-2029
6.7.5 UAE Lentivirus Particle Market Size, 2018-2029
7 Lentivirus Particle Companies Profiles
7.1 AMSBIO
7.1.1 AMSBIO Company Summary
7.1.2 AMSBIO Business Overview
7.1.3 AMSBIO Lentivirus Particle Major Product Offerings
7.1.4 AMSBIO Lentivirus Particle Revenue in Global Market (2018-2023)
7.1.5 AMSBIO Key News & Latest Developments
7.2 Creative Biogene
7.2.1 Creative Biogene Company Summary
7.2.2 Creative Biogene Business Overview
7.2.3 Creative Biogene Lentivirus Particle Major Product Offerings
7.2.4 Creative Biogene Lentivirus Particle Revenue in Global Market (2018-2023)
7.2.5 Creative Biogene Key News & Latest Developments
7.3 Cellomics Technology
7.3.1 Cellomics Technology Company Summary
7.3.2 Cellomics Technology Business Overview
7.3.3 Cellomics Technology Lentivirus Particle Major Product Offerings
7.3.4 Cellomics Technology Lentivirus Particle Revenue in Global Market (2018-2023)
7.3.5 Cellomics Technology Key News & Latest Developments
7.4 GenTarget
7.4.1 GenTarget Company Summary
7.4.2 GenTarget Business Overview
7.4.3 GenTarget Lentivirus Particle Major Product Offerings
7.4.4 GenTarget Lentivirus Particle Revenue in Global Market (2018-2023)
7.4.5 GenTarget Key News & Latest Developments
7.5 Takara Bio
7.5.1 Takara Bio Company Summary
7.5.2 Takara Bio Business Overview
7.5.3 Takara Bio Lentivirus Particle Major Product Offerings
7.5.4 Takara Bio Lentivirus Particle Revenue in Global Market (2018-2023)
7.5.5 Takara Bio Key News & Latest Developments
7.6 GeneCopoeia
7.6.1 GeneCopoeia Company Summary
7.6.2 GeneCopoeia Business Overview
7.6.3 GeneCopoeia Lentivirus Particle Major Product Offerings
7.6.4 GeneCopoeia Lentivirus Particle Revenue in Global Market (2018-2023)
7.6.5 GeneCopoeia Key News & Latest Developments
7.7 OriGene
7.7.1 OriGene Company Summary
7.7.2 OriGene Business Overview
7.7.3 OriGene Lentivirus Particle Major Product Offerings
7.7.4 OriGene Lentivirus Particle Revenue in Global Market (2018-2023)
7.7.5 OriGene Key News & Latest Developments
7.8 GenScript
7.8.1 GenScript Company Summary
7.8.2 GenScript Business Overview
7.8.3 GenScript Lentivirus Particle Major Product Offerings
7.8.4 GenScript Lentivirus Particle Revenue in Global Market (2018-2023)
7.8.5 GenScript Key News & Latest Developments
7.9 Addgene
7.9.1 Addgene Company Summary
7.9.2 Addgene Business Overview
7.9.3 Addgene Lentivirus Particle Major Product Offerings
7.9.4 Addgene Lentivirus Particle Revenue in Global Market (2018-2023)
7.9.5 Addgene Key News & Latest Developments
7.10 System Biosciences
7.10.1 System Biosciences Company Summary
7.10.2 System Biosciences Business Overview
7.10.3 System Biosciences Lentivirus Particle Major Product Offerings
7.10.4 System Biosciences Lentivirus Particle Revenue in Global Market (2018-2023)
7.10.5 System Biosciences Key News & Latest Developments
7.11 BPS Bioscience
7.11.1 BPS Bioscience Company Summary
7.11.2 BPS Bioscience Business Overview
7.11.3 BPS Bioscience Lentivirus Particle Major Product Offerings
7.11.4 BPS Bioscience Lentivirus Particle Revenue in Global Market (2018-2023)
7.11.5 BPS Bioscience Key News & Latest Developments
7.12 Charles River
7.12.1 Charles River Company Summary
7.12.2 Charles River Business Overview
7.12.3 Charles River Lentivirus Particle Major Product Offerings
7.12.4 Charles River Lentivirus Particle Revenue in Global Market (2018-2023)
7.12.5 Charles River Key News & Latest Developments
7.13 Santa Cruz Biotechnology
7.13.1 Santa Cruz Biotechnology Company Summary
7.13.2 Santa Cruz Biotechnology Business Overview
7.13.3 Santa Cruz Biotechnology Lentivirus Particle Major Product Offerings
7.13.4 Santa Cruz Biotechnology Lentivirus Particle Revenue in Global Market (2018-2023)
7.13.5 Santa Cruz Biotechnology Key News & Latest Developments
7.14 Sigma-Aldrich
7.14.1 Sigma-Aldrich Company Summary
7.14.2 Sigma-Aldrich Business Overview
7.14.3 Sigma-Aldrich Lentivirus Particle Major Product Offerings
7.14.4 Sigma-Aldrich Lentivirus Particle Revenue in Global Market (2018-2023)
7.14.5 Sigma-Aldrich Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report